Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
Condition(s):Chronic Graft Versus Host DiseaseLast Updated:December 29, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Chronic Graft Versus Host DiseaseLast Updated:December 29, 2023Recruiting
Condition(s):Graft vs. Host DiseaseLast Updated:March 4, 2020Completed
Condition(s):Graft vs Host DiseaseLast Updated:March 22, 2017Completed
Condition(s):Graft Versus Host DiseaseLast Updated:March 28, 2024Recruiting
Condition(s):Graft Versus Host Disease; GVHDLast Updated:July 21, 2021Completed
Condition(s):Graft -Versus-host-diseaseLast Updated:August 14, 2019Withdrawn
Condition(s):Stable Angina; Unstable Angina; Non-ST Segment Elevation Myocardial InfarctionLast Updated:January 10, 2023Completed
Condition(s):Acute Graft-versus-Host Disease; Allogeneic Stem Cell TransplantLast Updated:May 12, 2023Recruiting
Condition(s):Graft-versus-host Disease (GVHD)Last Updated:July 18, 2023Completed
Condition(s):Graft vs Host DiseaseLast Updated:November 11, 2014Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.